Clinical Trial

Serum Myostatin and Irisin Levels in Postmenopausal Women: Association With Bone Mineral Density and Muscle Strength

Study acronym: MYOIRISIN
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 9, 2026 (before its estimated May 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the relationship between serum myostatin and irisin levels and bone mineral density and muscle strength in postmenopausal women. Participants will be grouped according to bone mineral density as normal, osteopenic, or osteoporotic. Serum myostatin and irisin levels will be measured, and muscle strength will be assessed using handgrip strength and the five times sit-to-stand test. The associations between biochemical and functional parameters will be analyzed.
Trial Details
NCT Number NCT07519551
Lead Sponsor Kanuni Sultan Suleyman Training and Research Hospital
Collaborators: Saglik Bilimleri Universitesi
Conditions Osteoporosis, Osteopenia
Enrollment 60 participants
Start Date 2026-04-03
Primary Completion 2026-05-15 (estimated)
Study Completion 2026-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-09